January 2026 update

The text of the update Zhittya sent, word for word. Pictures, charts and layout are in the PDF. Open the PDF.

January 17, 2026, Monthly Update You are going to live 30 years longer than you think!

First: Happy New Year! I believe 2026 will be an amazing year and perhaps the most productive year of my life.

Zhittya has many wonderful items to report. First, I want to discuss a macro trend: You are going to live 30 years longer than you think! I am not guaranteeing that, but I am discussing what I believe is a 50% probability of the biggest advancement in life and health in human history. I believe this will also be a tremendous wealth generator for many people.

I believe that there are many amazing medical breakthroughs that have been discovered in the last 40 years that, if they were available to people now, would allow the average person to live 30 years longer, NOW!

In 1918, the life expectancy of a man in the United States was 39 years old. Over half of the people in this country died from a bacterial infection, with tuberculosis being the #1 cause of death. The discovery of antibiotics revolutionized healthcare to the point that we seldom die from bacterial infections. I would guess that 90% of the people alive today, between the ages of 20 and 25 years old, do not even know what tuberculosis is. Today, a child born has a life expectancy of 78 years, an over 100% increase in just 100 years.

I believe the biotechnology revolution started in 1953 with grasping what DNA was. In the 1960s, we began to understand our bodies' cellular mechanisms. In the 1980s, we began to understand how those cellular mechanisms integrated into full human body functions. Since 1985, over $12 trillion USD has been spent on medical research to develop drugs that trigger the process to grow new blood vessels to provide blood to heart muscle, another drug to eradicate tumors by destroying vascularization, drugs to treat Type-2 Diabetes, and more; all of which have stayed on the shelf and not reaching the sick people who need them. In the United States, 65% of all adults die from insufficient blood flow to a tissue or organ, such as heart attacks or strokes, while another 24% die from cancer. Together these two classes are responsible for the deaths of 89% of all adults, meaning if those treatments come to market, people will live longer and healthier! The secret to a long life is simple — don’t die!

I believe that there are many amazing medical breakthroughs that have been discovered in the last 40 years that, if they were available to people today, I believe they would allow the average person to live 30 years longer. Unfortunately, they are not available to you today. Zhittya’s FGF-1 was discovered in the mid-1980s, and research has shown it can treat small vessel heart disease, Parkinson’s disease, type 2 diabetes, and more. Yet in 25 years we have not been able to get through the US FDA approval process because of the many FDA Catch- 22 rules, which make no Common Sense. In 2006, the National Cancer Institute published a paper that in animal experiments a biological particle that they had developed eradicated naturally occurring cancer tumors in pet dogs. That has been left on the shelf for 19 years. Will it work in humans? I do not know. What I do know is that we have a duty to find out. How can such an amazing potential breakthrough not be pursued when millions of people are suffering and dying?

I believe over the next few years, we and others will be able to advance medical breakthroughs despite the USA FDA barrier because Zhittya is sponsoring the “Nevada Freedom to Try Medical Innovation, Nevada State Constitutional Initiative,” which, I believe, will create a pathway to the advancement of real medical discovery and progress. During the Consumer Electronics Show (CES), January 2026, Zhittya Genesis Medicine leveraged its connections with Korean companies to bring together a series of events, which saw over 15 Korean companies express interest in bringing their products and medical technology to the United States via Nevada. Many of these companies have cutting edge treatments for dementia, glaucoma, scoliosis, and more that have been denied access to the US market by the FDA. Below you will find pictures of Zhittya Genesis Medicine, the Lieutenant Governor of Nevada, and the Representative for the Republic of Korea, looking forward to the innovation that the Freedom to Try Medical Innovations will bring to Nevada, therefore the United States, then the world, and then to you.

From left to right: Brian Hardy Esq.; Stavros Anthony, Lieutenant Governor of Nevada; Dan Montano, CEO of Zhittya Genesis Medicine

From left to right: Heela Kim, Representative of the Republic of Korea; Sergiy Montano, Vice President of Marketing at Zhittya Genesis Medicine; Stavros Anthony, Lieutenant Governor of the State of Nevada; John Laub, CEO of WUND Healing Biopharmaceuticals. I am 77 years old. I have a chance today to live to be 87 years old, if I am lucky. I believe if I can live to 87, I could live another healthy 30 years as these medical discoveries continue to emerge from the Nevada Freedom to Try. Remember: if I do not die of cardiovascular diseases or cancers (89% of the cause of death), I have a solid chance to live longer. The secret to living longer is: Do not die!

Just over four years ago, Zhittya delivered a presentation titled “Why you will live 30 years longer than you think!” Here is a link to that presentation: https://www.youtube.com/watch?v=EIJE3PPQKLA

Zhittya should update this presentation with all the new discoveries we are seeing in the last 4 years. However, I am waiting until I have more data on:

1. Our 100-person Type-2 diabetes study that indicates that diabetes is curable, thereby extending the lives of 37 million Americans suffering with type-2 diabetes by 10 years or more.

2. I want to see how many more crazy ideas on how to cure cancer come to us from medical investigators because of the Freedom to Try. It has been exciting to hear so many unique ideas to eradicate cancer. The War Against Cancer was started in 1971 when US President Richard Nixon launched a massive government project to eradicate cancer. In over 50 years, the nominal death rate from cancer has remained about the same as in 1971. There have been some life extensions; however, in my opinion, 99% of the research is similar because cancer researchers all have the same ideas so they can get government funding for their research, and that funding is only provided to those with government acceptable concepts that, in 50 years, have proven not to work.

In the late 1800s, medical doctors in Vienna cured cancer by giving people Malaria. They observed that the body raises its internal temperature to 106F to fight the malaria infection, killing most if not all cancer cells, which die at ~104°F. Problem: many of the patients would succumb to the malaria itself. Is there a way to fix those issues? I do not know. But I think we should start freeing medical research investigators to find answers, rather than have them go speak at a conference on what we know does not work! Zhittya’s Medical Research Studies:

Type-2 Diabetes

We are now confident we have the optimal dosing for FGF-1 administered via the nose to treat type 2 diabetes. The results have been outstanding, with 90% reversing their type 2 diabetes within weeks. We are now learning what to do when the patient's glucose drops quickly. So far, reducing their diabetes medication has worked, but the discovery continues. Those who had horribly high glucose have seen their levels drop substantially; however, not sufficiently to be diabetes-free. It appears another round of dosing may be needed.

Parkinson’s Disease

We continue to see great improvements in our Parkinson’s disease subjects. We are also seeing that the higher doses of FGF- with the new device is definitely producing better results. We have over 250 people in our Parkinson’s Disease Medical Study, and we have to give all participants the best level of dosing when we discover it. So, the next few months will be busy getting all 250 up to the higher dosing levels. Our Parkinson’s treatment will now be conducted in Las Vegas in our partner’s clinic.

Heart Disease

We are starting to recruit heart patients so we can treat them in The Bahamas, where we have authorization to begin these studies. As a reminder, Zhittya’s FGF- 1 was initially used to treat coronary artery disease in no-option heart patients. Please watch the ABC News clip on our treatment for the heart here: https://www.youtube.com/watch?v=IPtv_0LWK4k Status: Zhittya’s Medical Research Studies Funding

Type-2 Diabetes:

Zhittya has effectively completed our Funding of the Medical Research Study to treat type-2 diabetes in Las Vegas for the first 100 patients. We are happy with the medical results so far. We are also pleased that with a very small marketing budget; we are obtaining about 250 new sign-ups per day for the type-2 diabetes study. It seems people who have diabetes do not want to keep it. I believe we should be completed with dosing by the end of March and have preliminary data by April/May. I am very pleased, so far.

No Option Heart Disease:

Zhittya will begin treating No-Option Heart Disease Patients in The Bahamas in January 2026. In my opinion, small vessel heart disease is the biggest unmet medical need in the world. The World Health Organization (WHO) reports that about 19 million people die from heart disease every year. I believe about 85% of those deaths are from small vessel disease, which your doctor may call congestive heart failure, so they do not have to explain small vessel disease. FGF-1 has been utilized in two human heart studies in Germany, showing FGF-1 is safe and triggers the growth of new blood vessels, thereby re-establishing critical blood supply to the heart muscle. We did a USA FDA-cleared Phase I to show it was safe, and it grew new blood vessels, thereby extending the lives of no-option heart patients by over ten years. See with your own eyes: https://www.youtube.com/watch?v=IPtv_0LWK4k

I believe 85% of the annual deaths due to small vessel disease are around 15 million people per year. People with small vessel disease or congestive heart failure are generally in pain from their heart condition and therefore know they have a life-ending medical situation. I believe people who know they have a life- or-death situation with their hearts and are within two years of death, would be 2 times 15 million, or 30 million people who know they have a life-ending heart condition, of which their medical doctors have told them there is “No Treatments for what they have” so prepare to die. Out of those 30 million people, the richest 1% would be 300,000 people, who have severe pains in their hearts and know they are at risk of dying and have a net worth estimated at more than $31 million USD per person. The richest 5% of the 30 million would be 1.5 million people, each with an estimated net worth of over $3.5 million.

I do not believe a person worth $30 million USD with severe and painful heart disease, with less than two years to live, is not seeking Zhittya’s heart treatment to extend his life maybe 10 or 15 or 20 years because he wants to save money to have a nicer funeral. I believe that the cardio-medical establishment is not telling those patients about Zhittya’s heart treatment because (1) they do not know about it, (2) it is not approved by the FDA, and (3) it is not within what they can offer as a treatment, so they do not offer it.

Dr. Conville S. Brown, cardiologist and principal of The Bahamas Heart Centre, Nassau, Bahamas, has obtained clearance from The National Medical Ethics Committee of The Bahamas (NMEC) to conduct a Medical Research Study to treat no-option heart disease patients in The Bahamas. The Zhittya team has visited Dr. Brown’s facilities in The Bahamas to perform heart procedures, and the facilities are first-class, with expert medical staff.

I believe the wealthiest 1% of no-option patients (net worth over $31 million USD each); for example, a man in Hamburg, Germany, has not decided to accept pain and death from his heart condition and rationally chosen not to seek Zhittya’s medicine to save his life. I believe he has not sought out the Zhittya heart treatment because his medical doctors have told him he is getting the best medical treatment in the world for his heart, and there is nothing else to do but die.

I believe Zhittya needs to raise global awareness that we can treat these millions of people and extend their lives. Towards that, Zhittya, along with Dr. Brown's

Bahamas Heart Centre, is conducting a 100-person Medical Research Study to treat no-option heart patients with FGF-1, as we have in three other 100% successful heart studies. Zhittya will be raising $10 million USD to fund this Medical Research Study for no-option heart patients, starting January 2026. I believe that since we have had 100% success and zero adverse events regarding the heart when confronted with certain death, many of those 1.5 million people (wealthiest 5% net worth of $3.5 million) will travel to the Bahamas to save and extend their lives.

I believe that as Zhittya treats thousands of patients who are suffering from no- option heart disease, it becomes more difficult for the FDA to ignore our treatment. Equally, Medicare is the largest payer of healthcare benefits in the world. From my sources, Medicare spends around $250,000 on a no-option heart patient in the last three years of their life. I believe Medicare should make Zhittya’s medicine “Standard of Care” for no-option heart patients available to all because its coverage will save Medicare tens of billions of dollars and enhance the lives of millions of retirees.

If this Medical Research Study breaks the FDA’s Catch-22 trap mindset and Common Sense is used, I believe in the USA and then, followed by the rest of the world, we can save millions of lives.

Medical Research Studies Funding for “Small Vessels Heart Disease” Investment Opportunity.

If you are interested in learning more about the Medical Research Study Funding to treat: Small Vessels Heart Disease investment opportunity (minimum investment of $25,000), please email me at Dan333@aol.com or call me at 702- 802-8373.

Investors will receive ten times their investment back from a Royalty of 50% of money Zhittya earned from the drug sales. If the investor is not happy at 48 months, Zhittya will buy back their investment at 2 times what they invested. I believe that investors might get their ten times return in a few years since I believe the demand among those rich people to save their lives and live longer will be strong.

If heart disease runs in your family, you might be able to invest, make money, and benefit your health and life. Besides making money, you can advance medical innovation to benefit millions of people.

As you have seen from the Type-2 Diabetes study, Zhittya did not have the extra money in June of 2025 to undertake this Medical Study activity then. Zhittya raised $5 million from investors, by offering a 50% royalty on all the cash sales of its drug to treat type 2 diabetes, paying them ten times their investment. This “Priming the Pump” 6 months ago allowed Zhittya to jumpstart developing its proof that FGF-1 can reverse Type-2 diabetes now, instead of in two years, when Zhittya would have the extra cash to conduct that study. When we complete that study in (I hope) April 2026 and report it to the world, Zhittya will start a 1,000- person Type-2 study (patient funded). I believe 30 million unique people travel to Nevada every year, so maybe 3 million of them have type 2 diabetes. If the 1,000- patient study shows the same results, a 90% reversal of diabetes, Zhittya then plans a 10,000-person study in 2027. How many people does Zhittya have to reverse their diabetes before the government can no longer ignore what we are doing? How long will 37 million Americans continue to suffer and die with diabetes; when they learn there is a simple, safe treatment to reverse diabetes in a few weeks? I believe the Medical Research Funding of Type-2 diabetes has moved forward Zhittya’s possible approval of its medicine to reverse type-2 diabetes by two to three years. Once approved, how many of the 37 million Americans will want it? How much will Medicare want our medicine approved if that would lower their cost of treating diabetics by hundreds of billions of dollars. Yes, Zhittya is paying those investors in our Diabetes Investment Fund 10 times their investment, or approximately $50 million USD. Once the medicine is approved and made available to all; I believe Zhittya’s sales will be hundreds of billions of dollars. Who among you would not pay $50 million to make many billions?

I believe Zhittya’s business model for treating the #1 cause of death in the world (small vessels heart disease) is a good deal for everyone

Our Las Vegas Principal Investigator for Zhittya’s Type-2 Diabetes, Parkinson’s Disease, and Enhanced Stroke Recovery Medical Research Studies was just named “Man of the Year” by MyVegas magazine:

Dr. Robert H. Odell, MD, PhD: Advancing Pain Relief and Functional Wellness in Las Vegas

Dr. Robert H. Odell, MD, PhD, is a respected physician and the founder of the Neuropathy and Pain Centers of Las Vegas, a practice dedicated to providing cutting-edge pain management coupled with holistic, functional wellness solutions. With a distinguished academic background and decades of clinical experience, Dr. Odell’s approach emphasizes personalized care that addresses both pain and overall wellness.

A Leader in Pain Medicine and Patient-Focused Care

Dr. Odell earned his dual degrees, an MD and a PhD in Biomedical Engineering, through rigorous training at Stanford University’s Medical Scientist Training Program. He completed his anesthesiology residency at UCLA, later serving as Chief Resident at Harbor-UCLA Medical Center. Dr Odell is board certified as a Diplomate of the American Board of Anesthesiology and the American Board of Pain Medicine, and is recognized as a Fellow of Interventional Pain Practice by the World Institute of Pain, including Diplomate status with the American Board of Anesthesiology and the American Board of Pain Medicine, these accomplishments reflect his commitment to excellence in advancing interventional pain care.

At the Neuropathy and Pain Centers of Las Vegas, Dr. Odell treats a wide range of musculoskeletal and neuropathic conditions using advanced diagnostics and treatments tailored to each patient’s needs. Vika’s Patients’ comments:

Zhittya has now dosed over 250 Parkinson’s disease patients, 30 diabetes patients, 5 stroke patients, 2 dementia patients, 2 autism patients, and more. We have not seen any adverse events, and there is zero pain, as the medicine is sprayed up the nose without breaking the skin. I provide these comments to make you aware of what I believe is an amazing success: Type 2 Diabetes Patient Comments:

Dr. Michael Type-2 Diabetes Patient:

“Vika, I think I survived the holidays well. I am very stable these days. It really looks good for me. No more meds! I am now concentrating on diet and exercise. Thank you sooooo much! Michael” Parkinson’s Disease Patient Comments:

Caregiver of Parkinson’s Disease Patient: “Good morning, his mind is getting clearer. I’m super excited to see how he does with the nebulizer style treatments.”

Cross Border Medical Tourism

Cross Border Medical Tourism services are for those people who want to be considered for Zhittya’s future clinical trials or its current Medical Research Studies. Cross Border is now arranging Medical Tourism to treat Parkinson’s disease in Las Vegas, starting January 2026

Cross Border is working on filling the Las Vegas Medical Research Studies (intranasal FGF-1 for Parkinson’s disease) on the following dates:

Cohort #43: January 26 – 29, 2026

Cohort #44: February 23 – 26, 2026 Cohort #45: March 23 – 26, 2026

Please contact Sam Cross at Cross Border Medical Tourism if you wish to be considered for the cohorts. Sam’s email address is:

Sam.crossbordermedical@gmail.com

Phone number: (714) 393-8605

In addition, if you are interested in participating in a functional MRI brain scan study at Washington University in St. Louis, please let Sam know. There is a finite number of slots for the imaging studies. These studies will look at brain blood flow before and after treatment with FGF-1.

Events:

January 20 – 22 Sequire Investor Summit in San Juan, Puerto Rico.

This is an investor conference expected to attract over 500 institutional investors. It seems that when there is snow in New York City, investors go to Puerto Rico!

Topic: Breakthrough Biotech Medicine: Treating the Cause of Death of 65% of all Adults If you are interested in attending this event, please email: dan333@aol.com January 28-29 “Dealflow Discovery Conference” The Borgata Hotel, Atlantic City, NJ.

This investor conference expects around 1,250 participants, focusing on companies like Zhittya that have high-growth potential.

Topic: Breakthrough Biotech Medicine: Treating the Cause of Death of 65% of all Adults.

If you are interested in attending this event, please email: dan333@aol.com

Conclusion by Dan Montano

Happy New Year!

I wish all of you a prosperous and healthy 2026.

The most important objective for Zhittya, I cannot discuss yet. Since the December 17 Update, there has been no progress on that very important subject.

I believe this Monthly Update now goes to over 100,000 people. We receive many emails back with comments. I want to address important questions that people ask: why have we stopped working on neuropathy? Why have you stopped working on Multiple Sclerosis? What is happening with autism? We have not stopped pursuing any of those diseases. We are working on more than 20 medical indications. Some go faster than others, and some, when we learn something new, get moved back in the line, because we must allocate our very limited resources to what we believe will bring the best outcomes for Zhittya as quickly as possible.

I believe FGF-1 can enhance the life of a person with autism. We believe the underdevelopment of blood vessels in the brain is the cause of autism. We believe FGF-1 can create new blood vessels and repair the brain's functions for a person. We have already dosed two autism subjects and seen some interesting positives. To rejuvenate vascularization in the brain of an autistic patient could require years of dosing to rebuild meaningful new blood flow. Years to get data that show our efforts are meaningful. We see that treating type 2 diabetes, we get results in weeks. Better still, the answer if we reversed type-2 diabetes in a person is binary. If their glucose level is 250, they are diabetic, and if lower than 125, they are not diabetic. In a few weeks from dosing someone, we have that answer, and then we have a major medical breakthrough of reversing diabetes for the hundreds of millions of people suffering with this horrible disease. We must prioritize medical indications with the shortest recovery time over those that take years to show improvement.

We get many complaints that our Updates are too long. I find that funny since we talk about less than 10% of what we are doing. Imagine how long it would be if I told you everything.

In 2026, if all we do is prove we can reverse type-2 diabetes, reverse Parkinson’s disease, and enhance recovery from small vessel heart disease, strokes, dementia, and neuropathy, I will be very proud of my very small team of great people at Zhittya. We will still have much to do; however, proving that we have treatments for these major diseases would be a good year. 2026 could be a great year for Zhittya. If the world learns about what we are doing and why FGF-1 is a miracle drug; my life would be better.

Zhittya fighting alone against the largest drug cartel in the world is not easy. However, since we are winning, I am happy!

Thank you!

Dan Montano, CEO Zhittya Genesis Medicine 8683 W. Sahara Ave., Suite 280 Las Vegas, NV 89117 USA 702-802-8373 zgm.care

<https://www.youtube.com/watch?v=EIJE3PPQKLA>

<https://www.youtube.com/watch?v=IPtv_0LWK4k>

<https://www.youtube.com/watch?v=IPtv_0LWK4k>

[mailto:Dan333@aol.com](mailto:Dan333@aol.com)

[mailto:Sam.crossbordermedical@gmail.com](mailto:Sam.crossbordermedical@gmail.com)

[mailto:dan333@aol.com](mailto:dan333@aol.com)

[mailto:dan333@aol.com](mailto:dan333@aol.com)

<https://www.zgm.care/>